Your search returned 26 studies. (Get alerts for new studies):
- Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Head and Neck Cancer - Intraocular Melanoma - Melanoma (Skin) - Non-melanomatous Skin Cancer - Precancerous Condition
1 Location available
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
Conditions: Melanoma (Skin)
1 Location available
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
220 Locations available
- Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
1 Location available
- Interferon Alfa-2b in Treating Patients Who Have Undergone Surgery for High-Risk or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Conditions: Melanoma (Skin)
1 Location available
- Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Melanoma (Skin)
2 Locations available
- Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Stage IV Melanoma That Has Been Removed By Surgery
Conditions: Melanoma (Skin)
1 Location available
- Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
11 Locations available
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
443 Locations available
- Chemotherapy and Total-Body Irradiation Followed By Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Vaccine Therapy in Treating Patients W
Conditions: Melanoma (Skin)
1 Location available
- RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Selumetinib With or Without Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or
Conditions: Melanoma (Skin)
4 Locations available
- Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
7 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
Conditions: Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
|